The FDA has given Amgen (AMGN) the green light to bring its breakthrough lung cancer drug Lumakras to the market. Amgen is a …
Amgen’s (AMGN) shares fell around 8% in early trading on Wednesday as the biopharmaceutical company reported disappointing results. Revenues fell 4% year-on-year to …
Amgen presented results from the Phase 3 ADVANCE trial of Otezla in patients with plaque psoriasis at the American Academy of Dermatology Virtual …
Amgen’s investigational treatment bemarituzumab has received Breakthrough Therapy Designation from the U.S.
Amgen Inc. has agreed to acquire private biopharmaceutical company Rodeo Therapeutics Corporation for a total consideration of $721 million.
Amgen has agreed to snap up clinical-stage biotech Five Prime Therapeutics for an equity value of $1.9 billion, to strengthen the company’s oncology …
Amgen announced on Jan. 29 that its experimental lung cancer drug, sotorasib, had been granted “Breakthrough Therapy Designation (BTD)” by the Center for …
Amgen (AMGN) and AstraZeneca (AZN) have announced positive topline results from the Phase 3 Navigator trial for tezepelumab, which demonstrated a statistically significant …
Amgen Inc.’ 3Q revenues jumped 12% to $6.
Amgen (AMGN) has announced an additional investment of approximately $421 million in BeiGene’s (BGNE) registered direct offering of ordinary shares. This investment maintains Amgen’s current …
